recent resurgence therapy particularly treatment prostate cancer warrants review original radiobiological basis modality evolution concepts resulted subsequent experimentation beams used randomized clinical trials clear current radiobiological knowledge postulates formed mechanistic basis past clinical trials incorrect discrepancies inherent physical disadvantages neutron beams terms collimation intensity modulation partially account lack therapeutic benefit observed randomized clinical trials equally apparent indiscriminate prescription therapy likely lead adverse clinical outcome proportion patients renewed efforts establish niche modality clinical radiation oncology necessitate development triage discriminate patients benefit therapy harmed future therapy prescribed based relative status appropriate molecular parameters differential impact radiosensitivity photons compared fast neutrons references NUMBER fast neutron fast neutron fast neutron fast neutron fast neutron